Why don’t all collected eggs become embryos?

Not every egg collected during IVF is mature, not every mature egg fertilises normally, and not every fertilised egg continues developing into an embryo suitable for transfer or freezing. These are different stages. A falling number is worth understanding, but it cannot, on its own, identify an egg, sperm or laboratory problem.

The difficult part is often the change in what a number means. You hear an egg count after collection, begin imagining possibilities, then receive a smaller number the next day. Another call brings a different milestone. It can feel as though the same result keeps getting worse. In fact, the team is reporting on a sequence of new questions.

Our Complete Guide to IVF explains the full pathway. Here, we focus on reading those laboratory updates so your next conversation can move beyond “Is this a good number?”

Collected, mature, fertilised: which number are you being given?

A follicle seen during a scan is not an egg already counted in the laboratory. After retrieval, the laboratory can report eggs recovered. Maturity is another observation, particularly important when ICSI is planned because that procedure involves injecting a sperm into a mature egg. The report then moves to whether fertilisation has occurred as expected.

Early embryo development adds another stage. Some embryos continue dividing; some do not progress to the point or meet the criteria used for transfer or freezing. Embryologists assess development and appearance, using observations that differ between an egg, a fertilised egg and a later embryo.

That is why “we collected twelve” and “six fertilised” are not two versions of one measurement. Ask for the maturity and insemination information between them before deciding what the difference means.

A simple example: keep the denominator with the result

Imagine a purely fictional sequence: twelve eggs collected, nine assessed as mature and injected, six normally fertilised, and two later assessed as suitable for the clinic's next step. These invented numbers illustrate the categories. They are not an expected rate, a patient case or a prediction.

If the question is fertilisation after ICSI, six out of the nine injected mature eggs is a different calculation from six out of the twelve collected eggs. Both calculations can be described accurately, but they answer different questions. If you compare your number with someone else's, first check that you are counting the same starting group and the same endpoint.

The same applies to “blast rate”. What day was assessed? Were all normally fertilised eggs included? Was an embryo transferred earlier? Does “usable” mean suitable for transfer, freezing or a further test? A percentage without those definitions can create more worry than understanding.

Where the change happens helps shape the review

A question about maturity is different from a question about fertilisation, which is different again from a question about later development. A useful cycle review therefore follows the sequence: stimulation and collection, maturity, insemination, fertilisation observations, then embryo development and selection.

This is a framework for asking, not a remote diagnosis. The report, treatment history, egg and sperm information and laboratory observations need to be considered together. The day an embryo stopped developing cannot reliably assign blame to one person.

Instead of “What is wrong with my eggs?”, try: “Which transition was unexpected in my cycle, and what information supports that interpretation?” That gives the team a specific finding to explain while leaving room for uncertainty.

Does this mean I need ICSI next time?

Not automatically. ICSI changes how fertilisation is attempted. It does not guarantee that an injected egg fertilises, develops to a blastocyst or leads to a baby. A history of poor or failed fertilisation can be relevant, but few later embryos do not by themselves establish the best insemination method.

ASRM's updated 2026 committee opinion makes the outcome distinction important: improved fertilisation in some settings does not establish improved live birth. Ask what the proposed technique is expected to change in your particular sequence, and what evidence supports that expectation.

Does a good embryo grade settle the question?

No. A grade describes assessed features of development and appearance; chromosome testing supplies a different kind of information. Neither label guarantees implantation or a baby. If genetic testing is being considered, ask about its purpose and limitations separately rather than treating it as another name for a better grade.

Longer culture can help selection among embryos, while some embryos may not continue developing to that stage. The appropriate culture and transfer plan needs discussion with the embryology and clinical team, especially when only a small number is available.

Five questions that make the next update more useful

1. What exactly was counted at each stage, and on which observation day?
2. Which finding, if any, was outside what you expected for my circumstances?
3. What do the clinical and embryology reports suggest together, and what remains uncertain?
4. What would the proposed investigation or treatment change—and would that action be reasonable without another test?
5. When will we review the plan, and who will explain the next decision?

Bring the actual cycle summary, not only the final embryo number. If a potentially modifiable factor or a targeted investigation is relevant, ask how it fits around the treating clinic's timetable. Further assessment can add useful information when there is a sound clinical question; it cannot promise to explain every loss of numbers or improve every outcome.

A laboratory report also cannot measure what this waiting has cost you emotionally. Ask for a clear update schedule and support during the gaps. You are allowed to want both honest information and a conversation that recognises how personal those numbers feel.

Understand the pathway around the numbers: read our Complete Guide to IVF, including preparation, ICSI, embryo decisions, safety and planning a useful review. For the separate sperm-assessment question, our semen-analysis guide explains what routine measurements can add.

Sources

• ESHRE/ALPHA: Istanbul Consensus update on oocyte and embryo morphological assessment (2025).
• HFEA: decisions about embryos, reviewed 2 June 2026.
• HFEA: ICSI and its role in fertilisation.
• ASRM: ICSI for nonmale factor indications, committee opinion (2026).
• HFEA: PGT-A, its purpose and evidence limitations.

Sources checked 18 October 2026. By ProFertility.